Trial intelligence / Profile preview

Nebulized Magnesium Sulfate in Pediatric Asthma

NCT00522444Phase 3Withdrawn

Sponsor
Cincinnati Children's Hospital Medical Center
Start
Sep 2007
Primary completion
Sep 2013
Modality
Small Molecules
01

Overview

A Phase 3 trial of magnesium sulfate in asthma, sponsored by Cincinnati Children's Hospital Medical Center. Planned start Sep 2007; status: withdrawn.

02

Drugs

magnesium sulfate
03

Conditions

asthma

Beyond the preview

Go deeper on NCT00522444.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00522444.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call